The KL2 Mentored Career Development Program (KL2 Scholars Program) at Stanford University is a two-year research program funded by the National Institutes of Health (NIH) and the Stanford Clinical Translational Science Award (CTSA) Program.
The Neuroscience:Translate program supports translational research addressing unmet needs in any area of neuroscience. Resulting technologies and therapies are intended to lead to licensing exits from the university to eventually reach the patient
c-ShARP welcomes collaborative proposals for instrument acquisitions, programs, or other enhancements to Shared Research Platforms and Shared Facilities that benefit the user community at large. Faculty & staff are welcome to apply.
We invite Stanford faculty, staff, and students across all disciplines to propose research and designs that will advance learning and lead to new insights in the area of virtual field trips.
The WHSDM Center aims to promote basic & translational, clinical, and population health research on sex differences and women’s health at the School of Medicine, and to foster collaborations on these topics across SoM depts and the University.
The EST Hub invites applications for funding to support the development of projects that advance understanding of ethical implications or societal impacts of science and technology innovation.
The Beckman Center for Molecular and Genetic Medicine announces this year’s call for proposals. 2-year grants of $200,000 ($100,000/year) for technology development in the biomedical sciences.
To support biomedical research in diabetes, the Stanford Diabetes Research Center (SDRC) invites applications for the 2021 Pilot and Feasibility (P&F) Program led by Dr. Fredric Kraemer.
The Stanford SPARK program supports the discovery and development of novel therapeutics and diagnostics that address unmet medical needs by offering funding, education and project-specific mentorship.
The IMA, CDCM and CCT, seek to accelerate the development of promising and innovative early-stage translational stem cell and gene therapies that fill unmet clinical needs.
